Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Bluejay Diagnostics, Inc. Common Stock (BJDX)

Surgical & Medical Instruments & Apparatus

https://www.bluejaydx.com

Bluejay Diagnostics Inc is a medical diagnostics company. It is engaged in developing, manufacturing, and marketing of clinical diagnostic products that improve the quality of medical diagnoses. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings. The company is a provider of rapid tests for infectious, inflammatory, and metabolic diseases by the Symphony platform.

360 MASSACHUSETTS AVENUE, SUITE 203
ACTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/10/2021

Market Cap

149,167

Shares Outstanding

1,240,000

Weighted SO

1,776,908

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

BBLG --.--%

TLIS --.--%

NUWE --.--%

HSCS --.--%

TIVC --.--%

NXL --.--%

INVO --.--%

MOTS --.--%

Beta

0.8080

Last Div

0.0000

Range

0.2507-65.6

Chg

-0.0415

Avg Vol

1348621

Mkt Cap

149167

Exch

NASDAQ

Country

US

Phone

844 327 7078

DCF Diff

1.4534

DCF

1.6766

Div Yield

0.0000

P/S

0.1029

EV Multiple

0.8089

P/FV

0.0148

Div Yield %

0.0000

P/E

-0.0136

PEG

0.0000

Payout

0.0000

Current Ratio

4.3845

Quick Ratio

4.3845

Cash Ratio

3.9178

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

468.9420

CCC

-468.9420

Gross Margin

0.7368

Op Margin

-6.6457

Pretax Margin

-6.4892

Net Margin

-6.4892

Eff Tax Rate

-0.0330

ROA

-0.8660

ROE

-1.8700

ROCE

-1.0942

NI/EBT

1.0000

EBT/EBIT

0.9764

EBIT/Rev

-6.6457

Debt Ratio

0.0393

D/E

0.0494

LT Debt/Cap

0.0171

Total Debt/Cap

0.0471

Int Coverage

29.5083

CF/Debt

-15.1428

Equity Multi

1.2567

Rec Turnover

0.0000

Pay Turnover

0.7783

Inv Turnover

0.0000

FA Turnover

0.7979

Asset Turnover

0.1335

OCF/Share

-13.3779

FCF/Share

-13.7873

Cash/Share

16.6784

OCF/Sales

-4.4600

FCF/OCF

1.0306

CF Coverage

-15.1428

ST Coverage

-23.4130

CapEx Coverage

-32.6738

Div&CapEx Cov

-32.6738

P/BV

0.0148

P/B

0.0148

P/S

0.1029

P/E

-0.0136

P/FCF

-0.0224

P/OCF

-0.0198

P/CF

-0.0198

PEG

0.0000

P/S

0.1029

EV Multiple

0.8089

P/FV

0.0148

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 17:58 Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering Benzinga Dec 28, 10:03 Dow Gains 50 Points; US Jobless Claims Rise To 218,000 GlobeNewswire Inc. Dec 27, 09:00 Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Revenue Product Segmentation